LIWANLI Financial Statements From 2010 to 2025

3054 Stock  TWD 24.90  0.45  1.84%   
LIWANLI Innovation financial statements provide useful quarterly and yearly information to potential LIWANLI Innovation Co investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on LIWANLI Innovation financial statements helps investors assess LIWANLI Innovation's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting LIWANLI Innovation's valuation are summarized below:
LIWANLI Innovation Co does not now have any fundamental ratios for analysis.
Check LIWANLI Innovation financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among LIWANLI Innovation's main balance sheet or income statement drivers, such as , as well as many indicators such as . LIWANLI financial statements analysis is a perfect complement when working with LIWANLI Innovation Valuation or Volatility modules.
  
This module can also supplement various LIWANLI Innovation Technical models . Check out the analysis of LIWANLI Innovation Correlation against competitors.

LIWANLI Innovation Co Company Current Valuation Analysis

LIWANLI Innovation's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current LIWANLI Innovation Current Valuation

    
  1.2 B  
Most of LIWANLI Innovation's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, LIWANLI Innovation Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, LIWANLI Innovation Co has a Current Valuation of 1.2 B. This is 91.68% lower than that of the Technology Hardware, Storage & Peripherals sector and significantly higher than that of the Information Technology industry. The current valuation for all Taiwan stocks is 92.81% higher than that of the company.

LIWANLI Innovation Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining LIWANLI Innovation's current stock value. Our valuation model uses many indicators to compare LIWANLI Innovation value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across LIWANLI Innovation competition to find correlations between indicators driving LIWANLI Innovation's intrinsic value. More Info.
LIWANLI Innovation Co is rated fifth in return on equity category among its peers. It also is rated fifth in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the LIWANLI Innovation's earnings, one of the primary drivers of an investment's value.

About LIWANLI Innovation Financial Statements

LIWANLI Innovation investors use historical fundamental indicators, such as LIWANLI Innovation's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in LIWANLI Innovation. Please read more on our technical analysis and fundamental analysis pages.
LIWANLI Innovation Co., Ltd. operates in the biomedical science industry. LIWANLI Innovation Co., Ltd. was founded in 1991 and is based in New Taipei City, Taiwan. LIWANLI INNOVATION operates under Drug ManufacturersSpecialty Generic classification in Taiwan and is traded on Taiwan Stock Exchange.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for LIWANLI Stock Analysis

When running LIWANLI Innovation's price analysis, check to measure LIWANLI Innovation's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LIWANLI Innovation is operating at the current time. Most of LIWANLI Innovation's value examination focuses on studying past and present price action to predict the probability of LIWANLI Innovation's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LIWANLI Innovation's price. Additionally, you may evaluate how the addition of LIWANLI Innovation to your portfolios can decrease your overall portfolio volatility.